Avricore Health Inc Cash Flow Conversion Efficiency

Latest as of March 2026: -0.130x

Avricore Health Inc cash flow conversion efficiency. Based on the latest financial reports, Avricore Health Inc (AVCR) has a cash flow conversion efficiency ratio of -0.130x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-25.44K ≈ $-18.40K USD) by net assets (CA$195.20K ≈ $141.21K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Avricore Health Inc (2000–2025)

Cash flow conversion efficiency of Avricore Health Inc from 2000 to 2025. This chart illustrates how Avricore Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AVCR share price today for real-time trading data and today's change.

Avricore Health Inc Cash Flow Conversion Ratio Explained

Avricore Health Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Avricore Health Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Avricore Health Inc ranked by their cash flow conversion efficiency. Also see AVCR market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
CAQ Holdings Ltd
AU:CAQ
-0.001x
QX Resources Ltd
AU:QXR
-0.084x
My Rewards International Ltd
AU:MRI
0.003x
EMPYREAN ENERGY LS-002
F:E1E
N/A
ROKMASTER Resources Corp
V:RKR
0.203x
Reklaim Ltd
V:MYID
-0.299x
Samfine Creation Holdings Group Limited
NASDAQ:SFHG
0.035x
Lucapa Diamond Company Ltd
AU:LOM
-0.039x

Annual Cash Flow Conversion Efficiency for Avricore Health Inc (2000–2025)

The table below shows the annual cash flow conversion efficiency of Avricore Health Inc from 2000 to 2025. Review Avricore Health Inc (AVCR) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$389.56K
≈ $281.80K
CA$-789.93K
≈ $-571.43K
-2.028x -497.17%
2024-12-31 CA$1.97 Million
≈ $1.42 Million
CA$1.00 Million
≈ $726.72K
0.511x +55.31%
2023-12-31 CA$2.01 Million
≈ $1.45 Million
CA$660.40K
≈ $477.73K
0.329x +247.46%
2022-12-31 CA$1.96 Million
≈ $1.42 Million
CA$-437.83K
≈ $-316.72K
-0.223x +60.32%
2021-12-31 CA$2.20 Million
≈ $1.59 Million
CA$-1.23 Million
≈ $-892.77K
-0.562x -132.79%
2020-12-31 CA$-714.04K
≈ $-516.53K
CA$-1.22 Million
≈ $-884.99K
1.713x +16.18%
2019-12-31 CA$-465.45K
≈ $-336.70K
CA$-686.41K
≈ $-496.54K
1.475x +175.74%
2018-12-31 CA$885.97K
≈ $640.89K
CA$-1.73 Million
≈ $-1.25 Million
-1.947x -175.22%
2017-12-31 CA$2.50 Million
≈ $1.81 Million
CA$-1.77 Million
≈ $-1.28 Million
-0.707x +34.26%
2016-12-31 CA$1.92 Million
≈ $1.39 Million
CA$-2.06 Million
≈ $-1.49 Million
-1.076x -81.28%
2015-12-31 CA$3.25 Million
≈ $2.35 Million
CA$-1.93 Million
≈ $-1.39 Million
-0.594x -34.10%
2014-12-31 CA$3.35 Million
≈ $2.43 Million
CA$-1.48 Million
≈ $-1.07 Million
-0.443x +45.59%
2013-12-31 CA$663.10K
≈ $479.67K
CA$-539.52K
≈ $-390.28K
-0.814x -129.81%
2012-12-31 CA$436.69K
≈ $315.89K
CA$-154.61K
≈ $-111.84K
-0.354x -897.35%
2011-12-31 CA$-1.32 Million
≈ $-955.71K
CA$-58.66K
≈ $-42.44K
0.044x -92.97%
2010-12-31 CA$-1.07 Million
≈ $-771.49K
CA$-673.34K
≈ $-487.08K
0.631x +104.18%
2009-12-31 CA$239.30K
≈ $173.10K
CA$-3.61 Million
≈ $-2.61 Million
-15.095x -2699.35%
2008-12-31 CA$1.73 Million
≈ $1.25 Million
CA$-930.62K
≈ $-673.20K
-0.539x -52.29%
2007-12-31 CA$2.48 Million
≈ $1.79 Million
CA$-876.72K
≈ $-634.21K
-0.354x +25.57%
2006-12-31 CA$779.90K
≈ $564.17K
CA$-371.02K
≈ $-268.39K
-0.476x +76.21%
2005-12-31 CA$157.37K
≈ $113.84K
CA$-314.66K
≈ $-227.62K
-1.999x -33.90%
2004-12-31 CA$271.03K
≈ $196.06K
CA$-404.72K
≈ $-292.77K
-1.493x -58.17%
2003-12-31 CA$800.22K
≈ $578.87K
CA$-755.46K
≈ $-546.49K
-0.944x -1330.14%
2002-12-31 CA$182.98K
≈ $132.37K
CA$14.04K
≈ $10.16K
0.077x +119.37%
2001-12-31 CA$184.42K
≈ $133.41K
CA$-73.06K
≈ $-52.85K
-0.396x -202.19%
2000-12-31 CA$79.95K
≈ $57.83K
CA$-10.48K
≈ $-7.58K
-0.131x --

About Avricore Health Inc

V:AVCR Canada Diagnostics & Research
Market Cap
$4.57 Million
CA$6.32 Million CAD
Market Cap Rank
#28705 Global
#1264 in Canada
Share Price
CA$0.05
Change (1 day)
+0.00%
52-Week Range
CA$0.05 - CA$0.09
All Time High
CA$8.32
About

Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to A… Read more